Rankings
▼
Calendar
OMER Q2 2024 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena
OMER
Omeros Corporation
$835M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$59M
Net Income
-$56M
EPS (Diluted)
$-0.97
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$46M
Free Cash Flow
-$46M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$356M
Total Liabilities
$481M
Stockholders' Equity
-$125M
Cash & Equivalents
$2M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$59M
-$41M
-44.6%
Net Income
-$56M
-$37M
-50.3%
← FY 2024
All Quarters
Q3 2024 →